Advances in toxicology and medical treatment of chemical warfare nerve agents

DARU, Journal of Pharmaceutical Sciences

Volumn 20, Issue 1, 2012, Pages

  Moshiri, Mohammd ^a   Darchini Maragheh, Emadodin ^a,b   Balali Mood, Mahdi ^b,c  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Chemical warfare agent; Iran; Magnesium sulfate; Nerve agents; Organophosphorous compounds; Pesticides; Sodium bicarbonate

Indexed keywords

ACETYLCHOLINE; ANTIOXIDANT; ATROPINE; BENACTYZINE; BICARBONATE; CHEMICAL WARFARE AGENT; CHOLINESTERASE; GACYCLIDINE; HYPOCHLORITE; MAGNESIUM SULFATE; METHYLPHOSPHONIC ACID; METHYLPHOSPHONOTHIOIC ACID S (2 DIISOPROPYLAMINOETHYL) O ETHYL ESTER; ORGANOPHOSPHATE PESTICIDE; ORGANOPHOSPHORUS COMPOUND; OXIME DERIVATIVE; PHOSPHODIESTERASE; RESIN; SARIN; SCAVENGER; SOMAN; TABUN; TEZAMPANEL; TRI ORTHO CRESYL PHOSPHATE;

BINDING SITE; BLOOD SAMPLING; CHEMICAL REACTION; CHEMICAL STRUCTURE; CHEMICAL WARFARE; CHOLINERGIC SYSTEM; CHOLINESTERASE INHIBITION; DETOXIFICATION; DISEASE SEVERITY; DRUG DISTRIBUTION; DRUG METABOLISM; ENVIRONMENTAL EXPOSURE; HEMOPERFUSION; HISTORY; HUMAN; HYDROLYSIS; HYPOTHALAMUS; MASS SPECTROMETRY; MOLECULAR WEIGHT; NONHUMAN; ORGANOPHOSPHATE POISONING; OXIDATION; PARASYMPATHETIC NERVE; PHARMACODYNAMICS; REVIEW; TREATMENT INDICATION; VICTIM;

EID: 84872483984     PISSN: 15608115     EISSN: 20082231     Source Type: Journal    
DOI: 10.1186/2008-2231-20-81     Document Type: Review

References (217)

1. Neurotoxic disorders of organophosphorus compounds and their managements. Balali-Mood M, Balali-Mood K, Arch Iran Med 2008 11 65 89 18154426 (Pubitemid 351233553)
2. Nerve agents: a review. Gunderson CH, Lehmann CR, Sidell FR, Jabbari B, Neurology 1992 42 946 950 10.1212/WNL.42.5.946 1315942
3. Complex view on poisoning with nerve agents and organophosphates. Bajgar J, Acta Medica (Hradec Kralove) 2005 48 3 21
4. Recent advances in the treatment of organophosphorous poisonings. Balali-Mood M, Saber H, IJMS 2012 37 74 91
5. Nerve agents. Newmark J, Neurologist 2007 13 20 32 10.1097/01.nrl. 0000252923.04894.53 17215724 (Pubitemid 46095581)
6. A review of nerve agent exposure for the critical care physician. Leikin JB, Thomas RG, Walter FG, Klein R, Meislin HW, Crit Care Med 2002 30 2346 2354 10.1097/00003246-200210000-00026 12394966 (Pubitemid 35191589)
7. Report of sixteen session of the scientific advisory board. OPCW, Book Report of sixteen session of the scientific advisory board pp. Available at: http://www.opcw.org/index.php?eID=dam-frontend-push&docID=14882. City; 4-6 April 2011.
8. Stewart CE, Weapons of mass casualties and terrorism response handbook London: Jones and Bartlett 2006
9. Recent advances in treatment of acute organophosphorous nerve agents poisoning. Balali-Mood M, Balali-Mood K, Hosseini Shirazi F, IJPR 2006 5 79 87
10. Fest C, Schmidt KJ, The chemistry of organophosphorus pesticides Berlin: Springer-Verlag 2 1982
11. Nerve agents. Newmark J, Neurol Clin 2005 23 623 641 10.1016/j.ncl.2004. 12.013 15757800 (Pubitemid 40332617)
12. Progress in Medical defense against nerve agents. Dunn MA, Sidell FR, JAMA 1998 262 649 652
13. Chemical warfare agents: II. Nerve agents. Sidell FR, Borak J, Ann Emerg Med 1992 21 865 871 10.1016/S0196-0644(05)81036-4 1610046
14. Organophosphate nerve agents. Marrs TC, Maynard RL, Sidell FR, Chemical warfare agents: toxicology and treatment New York: Wiley, Marrs TC, Maynard RL, Sidell FR, 1996 83 100
15. Treatment of organophosphate poisoning. Experience of nerve agents and acute pesticide poisoning on the effects of oximes. Balali-Mood M, Shariat M, J Physiol Paris 1998 92 375 378 10.1016/S0928-4257(99)80008-4 9789840 (Pubitemid 29046492)
16. Application of gas chromatography-mass spectrometry and gas chromatography-tandem mass spectrometry to the analysis of chemical warfare samples, found to contain residues of the nerve agent sarin, sulphur mustard and their degradation products. Black RM, Clarke RJ, Read RW, Reid MT, J Chromatogr A 1994 662 301 321 10.1016/0021-9673(94)80518-0 8143028 (Pubitemid 24075188)
17. Sidell FR, Maynard RL, Marrs TC, Chemical warfare agents: toxicology and treatment London: Wiley-Blackwell 2 Revised 2007 an imprint of John Wiley & Sons Ltd
18. Organophosphorus Compounds as Chemical Warfare Agents: a Review. Delfino RT, Ribeiro TS, Figueroa-Villar JD, J Braz Chem Soc 2009 20 407 428
19. Current understanding of the mechanisms involved in metabolic detoxification of warfare nerve agents. Jokanovic M, Toxicol Lett 2009 188 1 10 10.1016/j.toxlet.2009.03.017 19433263
20. The chemical warfare threat and the military healthcare provider. Takafuji ET, Kok AB, Textbook of military medicine Part I Warfare, weaponry, and the wasualty medical aspects of chemical and biological warfare Washington, DC: Borden Institute, Walter Reed Medical Center, Zajtchuk R, Bellamy RF, Sidell FR, 1997 111 128
21. Material Safety Data Sheet Lethal Nerve Agent Sarin (GB) Available at: http://www.gulfweb.org/bigdoc/report/appgb.html. Accessed Aguest 13, 2012
22. Sarin: guidelines on the management of victims of a nerve gas attack. Volans AP, J Accid Emerg Med 1996 13 202 206 10.1136/emj.13.3.202 8733661
23. Acetylcholinesterase plays a pivotal role in apoptosome formation. Park SE, Kim ND, Yoo YH, Cancer Res 2004 64 2652 2655 10.1158/0008-5472.CAN-04-0649 15087373 (Pubitemid 38500595)
24. Medical treatment of acute poisoning with organophosphorus and carbamate pesticides. Jokanovic M, Toxicol Lett 2009 190 107 115 10.1016/j.toxlet.2009.07. 025 19651196
25. Post-exposure therapy with recombinant human BuChE following percutaneous VX challenge in guinea-pigs. Mumford H, Troyer JK, Toxicol Lett 2011 206 29 34 10.1016/j.toxlet.2011.05.1016 21620937
26. Stoichiometric and catalytic scavengers as protection against nerve agent toxicity: a mini review. Lenz DE, Yeung D, Smith JR, Sweeney RE, Lumley LA, Cerasoli DM, Toxicology 2007 233 31 39 10.1016/j.tox.2006.11.066 17188793 (Pubitemid 46505351)
27. Recent advances in evaluation of oxime efficacy in nerve agent poisoning by in vitro analysis. Worek F, Eyer P, Aurbek N, Szinicz L, Thiermann H, Toxicol Appl Pharmacol 2007 219 226 234 10.1016/j.taap.2006.10.001 17112559 (Pubitemid 46282867)
28. Biotransformation of organophosphorus compounds. Jokanovic M, Toxicology 2001 166 139 160 10.1016/S0300-483X(01)00463-2 11543910 (Pubitemid 32822795)
29. Diagnostic aspects of organophosphate poisoning. Worek F, Koller M, Thiermann H, Szinicz L, Toxicology 2005 214 182 189 10.1016/j.tox.2005.06.012 16051411 (Pubitemid 41406258)
30. Interaction of organophosphorus compounds with carboxylesterases in the rat. Jokanovic M, Kosanovic M, Maksimovic M, Arch Toxicol 1996 70 444 450 10.1007/s002040050297 8740539 (Pubitemid 26128526)
31. Acute tabun toxicity; biochemical and histochemical consequences in brain and skeletal muscles of rat. Gupta RC, Patterson GT, Dettbarn WD, Toxicology 1987 46 329 341 10.1016/0300-483X(87)90213-7 3672538 (Pubitemid 17157705)
32. Organophosphates/nerve agent poisoning: mechanism of action, diagnosis, prophylaxis, and treatment. Bajgar J, Adv Clin Chem 2004 38 151 216 15521192
33. A comparison of in vivo and in vitro rates of ageing of soman-inhibited erythrocyte acetylcholinesterase in different animal species. Talbot BG, Anderson DR, Harris LW, Zarbrough LW, Lennox WJ, Drug Chem Toxicol 1988 11 A comparison of in vivo and in vitro rates of ageing of soman-inhibited erythrocyte acetylcholinesterase in different animal species
34. Role of carboxylesterase in soman, sarin and tabun poisoning in rats. Jokanovic M, Pharmacol Toxicol 1989 65 181 184 10.1111/j.1600-0773.1989.tb01152. x 2813290 (Pubitemid 19233799)
35. Factors modifying the toxicity of organophosphorous compounds including Soman and Sarin. Fonnum F, Sterri SH, Fundam Appl Toxicol 1981 1 143 147 7184780
36. Soman and sarin induce a long-lasting naloxone-reversible analgesia in mice. Clement JG, Copeman HT, Life Sci 1984 34 1415 1422 10.1016/0024-3205(84) 90055-9 6708739 (Pubitemid 14161210)
37. Evidence for nonacetylcholinesterase targets of organophosphorus nerve agent: supersensitivity of acetylcholinesterase knockout mouse to VX lethality. Duysen EG, Li B, Xie W, Schopfer LM, Anderson RS, Broomfield CA, Lockridge O, J Pharmacol Exp Ther 2001 299 528 535 11602663 (Pubitemid 32979664)
38. Hypothesis for synergistic toxicity of organophosphorus poisoning-induced cholinergic crisis and anaphylactoid reactions. Cowan FM, Shih TM, Lenz DE, Madsen JM, Broomfield CA, J Appl Toxicol 1996 16 25 33 10.1002/(SICI)1099- 1263(199601)16:1<25::AID-JAT303>3.0.CO;2-5 8821672
39. Present views on toxidynamics of soman poisoning. Bajgar J, Acta Med (Hradec Kralove) 1996 39 101 105
40. Oxidative stress in the mechanism of organophosphates neurotoxicity. Tonkopii V, Toxicol Lett 2003 144 132
41. Organophosphorus compounds. Lotti M, Experimental and clinical neurotoxicology New York: Oxford University Press, Spencer PS, Schaumburg HH, 2 2000 898 925
42. Protective activity of adenosine receptor agonists in the treatment of organophosphate poisoning. van Helden HP, Bueters TJ, Trends Pharmacol Sci 1999 20 438 441 10.1016/S0165-6147(99)01395-4 10542440 (Pubitemid 29528212)
43. Toxicity of the organophosphate chemical warfare agents GA, GB, and VX: implications for public protection. Munro N, Environ Health Perspect 1994 102 18 38 10.1289/ehp.9410218 9719666 (Pubitemid 24075499)
44. Cytotoxicity of organophosphate anticholinesterases. Cao CJ, Mioduszewski RJ, Menking DE, Valdes JJ, Katz EJ, Eldefrawi ME, Eldefrawi AT, In Vitro Cell Dev Biol Anim 1999 35 493 500 10.1007/s11626-999-0059-8 10548430 (Pubitemid 29530099)
45. Medical defense against nerve agents: New direction. Rickell DJ, Glenn JF, Houston WE, Milit Med 1987 152 35 41 (Pubitemid 17001391)
46. Retrospective detection of exposure to nerve agents: analysis of phosphofluoridates originating from fluoride-induced reactivation of phosphylated BuChE. van der Schans MJ, Polhuijs M, van Dijk C, Degenhardt CE, Pleijsier K, Langenberg JP, Benschop HP, Arch Toxicol 2004 78 508 524 15170525 (Pubitemid 39350146)
47. Method for the analysis of the methylphosphonic acid metabolites of sarin and its ethanol-substituted analogue in urine as applied to the victims of the Tokyo sarin disaster. Minami M, Hui DM, Katsumata M, Inagaki H, Boulet CA, J Chromatogr B Biomed Sci Appl 1997 695 237 244 10.1016/S0378-4347(97)00203-X 9300859 (Pubitemid 27339030)
48. Toxicokinetics of the nerve agent (+/-)-VX in anesthetized and atropinized hairless guinea pigs and marmosets after intravenous and percutaneous administration. van der Schans MJ, Lander BJ, van der Wiel H, Langenberg JP, Benschop HP, Toxicol Appl Pharmacol 2003 191 48 62 10.1016/S0041-008X(03)00216-3 12915103 (Pubitemid 36959963)
49. Military chemistry and chemical compounds. Field manual.Army Washington, DC: Department of the Air Force 1975
50. The sources, fate, and toxicity of chemical warfare agent degradation products. Munro NB, Talmage SS, Griffin GD, Waters LC, Watson AP, King JF, Hauschild V, Environ Health Perspect 1999 107 933 974 10.1289/ehp.99107933 10585900 (Pubitemid 30040578)
51. Relationship between the biodisposition of [3H]soman and its pharmacological effects in mice. Reynolds ML, Little PJ, Thomas BF, Bagley RB, Martin BR, Toxicol Appl Pharmacol 1985 80 409 420 10.1016/0041-008X(85)90385-0 4035696 (Pubitemid 15225513)
52. The binding of sarin in the blood plasma of the rat. Polak RL, Cohen EM, Biochem Pharmacol 1970 19 877 881 10.1016/0006-2952(70)90250-9 5507692
53. The influence of triorthocresylphosphate on the distribution of 32P in the body of the rat after the injection of 32P-sarin. Polak RL, Cohen EM, Biochem Pharmacol 1969 18 813 820 10.1016/0006-2952(69)90051-3 5788520
54. Tissue disposition of [3H]sarin and its metabolites in mice. Little PJ, Reynolds ML, Bowman ER, Martin BR, Toxicol Appl Pharmacol 1986 83 412 419 10.1016/0041-008X(86)90223-1 3705071 (Pubitemid 16084033)
55. Distribution of [3H] diisopropyl fluorophosphate, [3H]soman, [3H]sarin, and their metabolites in mouse brain. Little PJ, Scimeca JA, Martin BR, Drug Metab Dispos 1988 16 515 520 2903016
56. Urinary metabolites of sarin in a patient of the Matsumoto sarin incident. Nakajima T, Sasaki K, Ozawa H, Sekjima Y, Morita H, Fukushima Y, Yanagisawa N, Arch Toxicol 1998 72 601 603 10.1007/s002040050549 9806433 (Pubitemid 28457698)
57. Computational design of receptors for an organophosphate surrogate of the nerve agent soman. Allert M, Rizk SS, Looger LL, Hellinga HW, Proc Natl Acad Sci U S A 2004 101 7907 7912 10.1073/pnas.0401309101 15148405 (Pubitemid 38698027)
58. Identification of metabolites of nerve agent VX in serum collected from a victim. Tsuchihashi H, Katagi M, Nishikawa M, Tatsuno M, J Anal Toxicol 1998 22 383 388 9737333 (Pubitemid 28397535)
59. Quantitative analysis of O-isopropyl methylphosphonic acid in serum samples of Japanese citizens allegedly exposed to sarin: estimation of internal dosage. Noort D, Hulst AG, Platenburg DH, Polhuijs M, Benschop HP, Arch Toxicol 1998 72 671 675 10.1007/s002040050559 9851684 (Pubitemid 28523097)
60. Biomonitoring of exposure to chemical warfare agents: a review. Noort D, Benschop HP, Black RM, Toxicol Appl Pharmacol 2002 184 116 126 10.1006/taap.2002.9449 12408956 (Pubitemid 35339395)
61. Carbon nanotube-based electrochemical sensor for assay of salivary cholinesterase enzyme activity: an exposure biomarker of organophosphate pesticides and nerve agents. Wang J, Timchalk C, Lin Y, Environ Sci Technol 2008 42 2688 2693 10.1021/es702335y 18505017 (Pubitemid 351482950)
62. Biomarkers of organophosphorus (OP) exposures in humans. Marsillach J, Richter RJ, Kim JH, Stevens RC, MacCoss MJ, Tomazela D, Suzuki SM, Schopfer LM, Lockridge O, Furlong CE, Neurotoxicology 2011 32 656 660 10.1016/j.neuro.2011. 06.005 21767566
63. Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) for detection and identification of albumin phosphylation by organophosphorus pesticides and G- and V-type nerve agents. John H, Breyer F, Thumfart JO, Hochstetter H, Thiermann H, Anal Bioanal Chem 2010 398 2677 2691 10.1007/s00216-010-4076-y 20730528
64. Preliminary studies in the formation of ethyl methylphosphonofluoridate from rat and human serum exposed to VX and treated with fluoride ion. Jakubowski M, Heykamp LS, Durst HD, Thomson SA, Anal Lett 2001 4 727 747
65. History and perspectives of bioanalytical methods for chemical warfare agent detection. Black RM, J Chromatogr B Analyt Technol Biomed Life Sci 2010 878 1207 1215 10.1016/j.jchromb.2009.11.025 20018570
66. New method for retrospective detection of exposure to organophosphorus anticholinesterases: application to alleged sarin victims of Japanese terrorists. Polhuijs M, Langenberg JP, Benschop HP, Toxicol Appl Pharmacol 1997 146 156 161 10.1006/taap.1997.8243 9299607 (Pubitemid 27406407)
67. Detection of the sarin hydrolysis product in formalin-fixed brain tissues of victims of the Tokyo subway terrorist attack. Matsuda Y, Nagao M, Takatori T, Niijima H, Nakajima M, Iwase H, Kobayashi M, Iwadate K, Toxicol Appl Pharmacol 1998 150 310 320 10.1006/taap.1998.8428 9653062 (Pubitemid 28302515)
68. Retrospective detection of exposure to organophosphorus anti-cholinesterases: mass spectrometric analysis of phosphylated human butyrylcholinesterase. Fidder A, Hulst AG, Noort D, de Ruiter R, van der Schans MJ, Benschop HP, Langenberg JP, Chem Res Toxicol 2002 15 582 590 10.1021/tx0101806 11952345 (Pubitemid 34406420)
69. Comparison of early and late toxic effects of sulfur mustard in Iranian veterans. Balali-Mood M, Hefazi M, Basic Clin Pharmacol Toxicol 2006 99 273 282 10.1111/j.1742-7843.2006.pto-429.x 17040211 (Pubitemid 44578902)
70. DM P, Environment committee armed forces epidemiological board long-term health effects associated with sub-clinical exposures to GB and mustard 1996 Gulf link: Office of the special assistant for Gulf War Illnesses,Available at: http://www.gul-ink.osd.mil/agent.html.
71. Central respiratory effects versus neuromuscular actions of nerve agents. Rickett DL, Glenn JF, Beers ET, Neurotoxicology 1986 7 225 236 3714123 (Pubitemid 16116635)
72. Arrhythmias in organophosphate poisoning: effect of atropine and bispyridinium oximes. Worek F, Kleine A, Falke K, Szinicz L, Arch Int Pharmacodyn Ther 1995 329 418 435 8546540
73. Soman and sarin: clinical manifestations and treatment of accidental poisoning by organophosphates. Sidell FR, Clin Toxicol 1974 7 1 17 10.3109/15563657408987971 4838227
74. Accidental exposure to sarin: vision effects. Rengstorff RH, Arch Toxicol 1985 56 201 203 10.1007/BF00333427 3977601
75. Secondary exposure of medical staff to sarin vapor in the emergency room. Nozaki H, Hori S, Shinozawa Y, Fujishima S, Takuma K, Sagoh M, Kimura H, Ohki T, Suzuki M, Aikawa N, Intensive Care Med 1995 21 1032 1035 10.1007/BF01700667 8750130 (Pubitemid 26009319)
76. Marrs TC, Maynard RL, Sidell FR, Chemical warfare agents. Toxicology and treatment Toronto: J. Wiley and Sons 1996
77. Nerve agents. US Army Medical Research Institute of Chemical Defense, Medical management of chemical casualties handbook Edgewood: Aberdeen Proving Ground 3 1998
78. Resuscitation of dogs poisoned by inhalation of the nerve gas GB. Christensen MK, Crethull P, Crook JW, Oberst FW, Ross RS, Umland CW 2nd, Mil Med 1956 119 377 386 13378091
79. Q-T prolongation and polymorphous («torsade de pointes») ventricular arrhythmias associated with organophosphorus insecticide poisoning. Ludomirsky A, Klein HO, Sarelli P, Becker B, Hoffman S, Taitelman U, Barzilai J, Lang R, David D, DiSegni E, Kaplinsky E, Am J Cardiol 1982 49 1654 1658 10.1016/0002-9149(82)90242-9 7081053 (Pubitemid 12003476)
80. Cardiomyopathy in Soman and Sarin intoxicated rats. Singer AW, Jaax NK, Graham JS, McLeod CG Jr, Toxicol Lett 1987 36 243 249 10.1016/0378-4274(87) 90192-5 3590220 (Pubitemid 17098947)
81. Electrophysiological changes in patients with acute organophosphorous pesticide poisoning. Jalali N, Balali-Mood M, Jalali I, Shakeri MT, Basic Clin Pharmacol Toxicol 2012 108 251 255
82. An assessment of comparative acute toxicity of diisopropyl- fluorophosphate, tabun, sarin, and soman in relation to cholinergic and GABAergic enzyme activities in rats. Sivam SP, Hoskins B, Ho IK, Fundam Appl Toxicol 1984 4 531 538 6479498 (Pubitemid 14037940)
83. Nerve agents. Balali-Mood M, Balali-Mood K, Critical Care Toxicology Philadelphia, USA: Elsevier Mosby, Brent J, 2005 1379 1393
84. Heide EA, Cholinesterase inhibitors: Including insecticides and chemical warfare nerve agents Part 5: The intermediate syndrome 2012 2012 Agency for toxic substances and disease registry (ATSDR), Avalable at: http://www.atsdr. cdc.gov/csem/csem.asp?csem=11&po=28
85. Central respiratory effects versus neuromuscular actions of nerve agents. Rickett D, Glenn J, Beers ET, Neurotoxicology 1953 8 466 475
86. Cholinergic symptoms due to nerve agent attack: a strategy for management. Schecter WP, Anesthesiol Clin North America 2004 22 579 590 viii 10.1016/j.atc.2004.04.005 15325720 (Pubitemid 39119847)
87. A comprehensive review on experimental and clinical findings in intermediate syndrome caused by organophosphate poisoning. Abdollahi M, Karami-Mohajeri S, Toxicol Appl Pharmacol 2012 258 309 314 10.1016/j.taap.2011. 11.014 22177963
88. Serial neuro-electrophysiological studies in acute organophosphate poisoning-correlation with clinical findings, serum cholinesterase levels and atropine dosages. Avasthi G, Singh G, J Assoc Physicians India 2000 48 794 799 11273471
89. Chapter 9,Long-term health effects of chemical threat agents. Smith WJ, Clark MWG, Talbot TB, Caple PA, Sidell FR, Hurst CG, Textbooks of military medicine,medical aspects of chemical warfare Washington, DC: The Office of the Surgeon General at TMM Publications, Lenhart MK, Tuorinsky SD, 2008 311 338
90. Possible immediate and long-term health effects following exposure to chemical warfare agents. Karalliedde L, Wheeler H, Maclehose R, Murray V, Public Health 2000 114 238 248 10962584 (Pubitemid 30639413)
91. Organophosphorus-induced delayed neuropathy: a simple and efficient therapeutic strategy. Emerick GL, Peccinini RG, de Oliveira GH, Toxicol Lett 2010 192 238 244 10.1016/j.toxlet.2009.10.032 19914363
92. Organophosphate induced delayed polyneuropathy in man: an overview. Jokanovic M, Kosanovic M, Brkic D, Vukomanovic P, Clin Neurol Neurosurg 2011 113 7 10 10.1016/j.clineuro.2010.08.015 20880629
93. Delayed Neurological Complications of Sulphur Mustard and Tabun Poisoning in 43 Iranian Veterans. Darchini-Maragheh E, Nemati-Karimooy H, Hasanabadi H, Balali-Mood M, Basic Clin Pharmacol Toxicol 2012 111 426 432 22762514
94. Clinical and paraclinical fndings in 233 patients with sulfur mustard poisoning. Balali-Mood M, Navaeian A, Proceedings of the second world congress on new compounds in biological and chemical warfare, toxicological evaluation Ghent, Belgium: Ghent University Press, Heyndrickx B, 1986 464 473
95. Can we prevent a second 'Gulf War syndrome'? Population-based healthcare for chronic idiopathic pain and fatigue after war. Engel CC, Jaffer A, Adkins J, Riddle JR, Gibson R, Adv Psychosom Med 2004 25 102 122 15248370
96. Evolution of and perspectives on therapeutic approaches to nerve agent poisoning. Masson P, Toxicol Lett 2011 206 5 13 10.1016/j.toxlet.2011.04.006 21524695
97. Comparison of status epilepticus models induced by pilocarpine and nerve agents-a systematic review of the underlying aetiology and adopted therapeutic approaches. Tang FR, Loke WK, Ling EA, Curr Med Chem 2011 18 886 899 10.2174/092986711794927720 21182477
98. Sarin poisoning of a rescue team in the Matsumoto sarin incident in Japan. Nakajima T, Sato S, Morita H, Yanagisawa N, Occup Environ Med 1997 54 697 701 10.1136/oem.54.10.697 9404315 (Pubitemid 27414491)
99. Behavioral and psychological responses to chemical and biological warfare. Fullerton CS, Ursano RJ, Mil Med 1990 155 54 59 2106650 (Pubitemid 20086140)
100. Long-term health effects of exposure to sarin and other anticholinesterase chemical warfare agents. Page WF, Mil Med 2003 168 239 245 12685692 (Pubitemid 36331733)
101. Single whole-body exposure to sarin vapor in rats: long-term neuronal and behavioral deficits. Grauer E, Chapman S, Rabinovitz I, Raveh L, Weissman BA, Kadar T, Allon N, Toxicol Appl Pharmacol 2008 227 265 274 10.1016/j.taap.2007. 11.006 18164360
102. Sidell FR, Newmark J, McDonough JH, Textbooks of military medicine,medical aspects of chemical warfare Washington D.C: Department of the Army, United States of America, Lenhart MK, Tuorinsky SD, 2008 155 219
103. Retention of inhaled sarin vapor and its effect on red blood cell cholinesterase activity in man. Oberst FW, Koon WS, Christensen MK, Crook JW, Cresthull P, Freeman G, Clin Pharmacol Ther 1968 9 421 427 5655475
104. Antidotes for nerve agent poisoning: should we differentiate children from adults? Baker MD, Curr Opin Pediatr 2007 19 211 215 10.1097/MOP. 0b013e328012cba2 17496768 (Pubitemid 46668076)
105. A review article on nerve agents. Tang SYH, Chan JTS, Hong Kong jemergmed 2002 9 83 89
106. Drug information online (drug.com) 2012 ATNAA. http://www.drugs.com/pro/ atnaa.html
107. The role of oximes in the treatment of nerve agent poisoning in civilian casualties. Marrs TC, Rice P, Vale JA, Toxicol Rev 2006 25 297 323 10.2165/00139709-200625040-00009 17288500
108. Nerve gas attack. Yergler M, Am J Nurs 2002 102 57 60 12394059
109. Review of health consequences from high-, intermediate- and low-level exposure to organophosphorus nerve agents. Brown MA, Brix KA, J Appl Toxicol 1998 18 393 408 10.1002/(SICI)1099-1263(199811/12)18:6<393::AID-JAT528>3. 0.CO;2-0 9840747 (Pubitemid 28522041)
110. ATSDR, Medical management guidelines for Nerve Agents: Tabun (GA); Sarin (GB); Soman (GD); and VX 2012 Agency for toxic substances and disease registry http://www.atsdr.cdc.gov/MHMI/mmg166.pdf
111. The effects of varying doses of atropine on temperature regulation of men and dogs. Robinson S, Magenis TP, Minter DI, Harper H, The Physiological Effects of Atropine and Potential Atropine Substitutes Edgewood Arsenal, MD: Medical Research Laboratories, Robinson S, 1953
112. Consequence management in the 1995 Sarin attacks on the Japanese subway system. Pangi B, Stud Confli Terrorri 2002 25 421 448 10.1080/10576100290101296
113. Anonymus, ACT FAST,Agent Characteristics and Toxicology, First Aid and Special Treatment,Student gauidline U.S. Department of the Army 2007
114. Decontamination. Hurst CG, Textbooks of military medicine,medical aspects of chemical warfare Washington D.C: Department of the Army, United States of America, Lenhart MK, Tuorinsky SD, 2008 351 359
115. Direct detection of the hydrolysis of nerve agent model compounds using a fluorescent probe. Zheng X, Okolotowicz K, Wang B, Macdonald M, Cashman JR, Zhang J, Chem Biol Interact 2010 187 330 334 10.1016/j.cbi.2010.01.027 20097185
116. Degradation of nerve agents by an organophosphate-degrading agent (OpdA). Dawson RM, Pantelidis S, Rose HR, Kotsonis SE, J Hazard Mater 2008 157 308 314 10.1016/j.jhazmat.2007.12.099 18258361
117. Sulfur mustard. Balali Mood M, Balali Mood B, Moshiri M, Encyclopedia of Toxicology Elsevier, Wexler P, Greim H, Moser V, Wiegand TJ, Lafarga JVT, Peyster A, Harper S, Abdollahi M, Gad SC, Ray SD, 2012 in press
118. Effect of high doses of sodium bicarbonate in acute organophosphorous pesticide poisoning. Balali-Mood M, Ayati MH, Ali-Akbarian H, Clin Toxicol (Phila) 2005 43 571 574 10.1081/CLT-200068845 (Pubitemid 41446737)
119. Interaction of monotopic membrane enzymes with a lipid bilayer: a coarse-grained MD simulation study. Balali-Mood K, Bond PJ, Sansom MS, Biochemistry 2009 48 2135 2145 10.1021/bi8017398 19161285
120. Skin decontamination: Importance of the wash-in effect. Moody RP, Maibach HI, Food Chemic Toxico 2006 44 1783 1788 10.1016/j.fct.2006.05.020 (Pubitemid 44895303)
121. Decontamination of chemical and biological warfare agents. Seto Y, Yakugaku Zasshi 2009 129 53 69 10.1248/yakushi.129.53 19122437
122. Chemical warfare poisoning in time of peace. Ishoj T, Jensen K, Ugeskr Laeger 1999 161 808 810 10028889
123. Median lethal dose determination for percutaneous exposure to soman and VX in guinea pigs and the effectiveness of decontamination with M291 SDK or SANDIA foam. Clarkson ED, Schulz SM, Railer RF, Smith KH, Toxicolo Lette 2012 212 282 287 10.1016/j.toxlet.2012.05.028
124. Chemical weapons: documented use and compounds on the horizon. Bismuth C, Borron SW, Baud FJ, Barriot P, Toxicolo Lette 2004 149 11 18 10.1016/j.toxlet.2003.12.016 (Pubitemid 38469815)
125. Alteromonas prolidase for organophosphorus G-agent decontamination. Cheng TC, DeFrank JJ, Rastogi VK, Chem Biol Interact 1999 119-120 455 462 23131608 (Pubitemid 29278583)
126. A cloned bacterial enzyme for nerve agent decontamination. Cheng TC, Calomiris JJ, Enzy Microb Technolo 1996 18 597 601 10.1016/0141-0229(95)00152-2 (Pubitemid 26202560)
127. Detoxification of organophosphate nerve agents by bacterial phosphotriesterase. Ghanem E, Raushel FM, Toxicol Appl Pharmacol 2005 207 459 470 10.1016/j.taap.2005.02.025 15982683 (Pubitemid 41265548)
128. Organophosphate skin decontamination using immobilized enzymes. Gordon RK, Feaster SR, Russell AJ, LeJeune KE, Maxwell DM, Lenz DE, Ross MC, Doctor BP, Chem Biol Interact 1999 119-120 463 470 23131608 (Pubitemid 29278584)
129. Nerve Agents. Wang RF, Wang TL, Disaster Med 2005 4 Suppl 1 29 S34
130. Nerve agents (GA, GB, GD, VX). ATSDR, Agency for toxic substances and disease registry, division of toxicology 2012 http://www.atsdr.cdc.gov/toxfaqs/ tfacts166.pdf
131. Nerve agents: implications for anesthesia providers. Hrobak PK, AANA J 2008 76 95 97 18478812 (Pubitemid 351521187)
132. Organic phosphorus compounds - nerve agents. Barthold CL, Schier JG, Crit Care Clin 2005 21 673 689 v-vi 10.1016/j.ccc.2005.05.010 16168308 (Pubitemid 41306211)
133. The birth of nerve agent warfare: lessons from Syed Abbas Foroutan. Newmark J, Neurology 2004 62 1590 1596 10.1212/01.WNL.0000124519.85516.50 15136687 (Pubitemid 38608201)
134. Speed of initial atropinisation in significant organophosphorus pesticide poisoning-a systematic comparison of recommended regimens. Eddleston M, Buckley NA, Checketts H, Senarathna L, Mohamed F, Sheriff MH, Dawson A, J Toxicol Clin Toxicol 2004 42 865 875 10.1081/CLT-200035223 15533026 (Pubitemid 39426213)
135. Therapeutic and neuroprotective efficacy of pharmacological pretreatment and antidotal treatment of acute tabun or soman poisoning with the emphasis on pretreatment drug PANPAL. Kassa J, Arh Hig Rada Toksikol 2006 57 427 434 17265682 (Pubitemid 46032879)
136. Meprobamate-benactyzine (Deprol) and placebo in two depressed outpatient populations. McLaughlin B, Rickels K, Abidi M, Toro R, Psychosomatics 1969 10 73 81 4891208
137. The Importance of Lipid-Solubility for the Central Action of Cholinolytic Drugs. Herz A, Teschemacher H, Hofstetter A, Kurz H, Int J Neuropharmacol 1965 4 207 218 10.1016/0028-3908(65)90037-7 14343875
138. Anticonvulsant treatment of nerve agent seizures: anticholinergics versus diazepam in soman-intoxicated guinea pigs. McDonough JH Jr, Zoeffel LD, McMonagle J, Copeland TL, Smith CD, Shih TM, Epilepsy Res 2000 38 1 14 10604601 (Pubitemid 30055311)
139. The role of oximes in the management of organophosphorus pesticide poisoning. Eyer P, Toxicol Rev 2003 22 165 190 10.2165/00139709-200322030-00004 15181665 (Pubitemid 38659720)
140. Mechanism of organophosphates (nerve gases and pesticides) and antidotes: electron transfer and oxidative stress. Kovacic P, Curr Med Chem 2003 10 2705 2709 10.2174/0929867033456314 14529460 (Pubitemid 37456040)
141. Neuropharmacological Mechanisms of Nerve Agent-induced Seizure and Neuropathology. McDonough JH Jr, Shih T-M, Neurosci Biobehav Rev 1997 21 559 579 10.1016/S0149-7634(96)00050-4 9353792 (Pubitemid 27458800)
142. Review of oximes in the antidotal treatment of poisoning by organophosphorus nerve agents. Kassa J, J Toxicol Clin Toxicol 2002 40 803 816 10.1081/CLT-120015840 12475193 (Pubitemid 35428793)
143. The development of new oximes and the evaluation of their reactivating, therapeutic and neuroprotective efficacy against tabun. Kassa J, Kuca K, Karasova J, Musilek K, Mini Rev Med Chem 2008 8 1134 1143 10.2174/ 138955708785909871 18855728
144. Reactivators of acetylcholinesterase inhibited by organophosphorus nerve agents. Mercey G, Verdelet T, Renou J, Kliachyna M, Baati R, Nachon F, Jean L, Renard PY, Acc Chem Res 2012 45 756 766 10.1021/ar2002864 22360473
145. Increased morbidity and mortality in acute human organophosphate-poisoned patients treated by oximes: a meta-analysis of clinical trials. Rahimi R, Nikfar S, Abdollahi M, Hum Exp Toxicol 2006 25 157 162 10.1191/0960327106ht602oa 16634335
146. PAM-2 Cl, HI-6, and HGG-12 in soman and tabun poisoning. Boskovic B, Kovacevic V, Jovanovic D, Fundam Appl Toxicol 1984 4 106 115 10.1016/0272-0590(84)90142-8 6724203 (Pubitemid 14005966)
147. A comparison of the potency of the oxime HLo-7 and currently used oximes (HI-6, pralidoxime, obidoxime) to reactivate nerve agent-inhibited rat brain acetylcholinesterase by in vitro methods. Kuca K, Cabal J, Kassa J, Jun D, Hrabinova M, Acta Medica (Hradec Kralove) 2005 48 81 86
148. In vitro potency of H oximes (HI-6, HLo-7), the oxime BI-6, and currently used oximes (pralidoxime, obidoxime, trimedoxime) to reactivate nerve agent-inhibited rat brain acetylcholinesterase. Kuca K, Cabal J, Kassa J, Jun D, Hrabinova M, J Toxicol Environ Health A 2006 69 1431 1440 10.1080/ 15287390500364283 16766478 (Pubitemid 44464391)
149. Treatment of intoxication with GV compound in laboratory rats. Fusek J, Bajgar J, Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove 1994 37 57 62 7784799
150. A comparison of the potency of newly developed oximes (K074, K075) and currently available oximes (obidoxime, trimedoxime, HI-6) to counteract acute toxic effects of tabun and cyclosarin in mice. Kassa J, Humlicek V, Drug Chem Toxicol 2008 31 127 135 10.1080/01480540701688816 18161512
151. Comparison of reactivating and therapeutic efficacy of two salts of the oxime HI-6 against tabun, soman and cyclosarin in rats. Kassa J, Jun D, Kuca K, Bajgar J, Basic Clin Pharmacol Toxicol 2007 101 328 332 10.1111/j.1742-7843. 2007.00126.x 17910616 (Pubitemid 47512385)
152. A comparison of reactivating efficacy of newly developed oximes (K074, K075) and currently available oximes (obidoxime, HI-6) in cyclosarin-and tabun-poisoned rats. Kassa J, Jun D, Kuca K, J Enzyme Inhib Med Chem 2007 22 297 300 10.1080/14756360601114361 17674811 (Pubitemid 47225722)
153. A comparison of reactivating efficacy of newly developed oximes (K074, K075) and currently available oximes (obidoxime, HI-6) in soman, cyclosarin and tabun-poisoned rats. Kassa J, Jun D, Karasova J, Bajgar J, Kuca K, Chem Biol Interact 2008 175 425 427 10.1016/j.cbi.2008.05.001 18547554
154. A comparison of tabun-inhibited rat brain acetylcholinesterase reactivation by three oximes (HI-6, obidoxime, and K048) in vivo detected by biochemical and histochemical techniques. Bajgar J, Hajek P, Zdarova JK, Kassa J, Paseka A, Slizova D, Krs O, Kuca K, Jun D, Fusek J, Capek L, J Enzyme Inhib Med Chem 2010 25 790 797 10.3109/14756360903433373 21054236
155. Reactivation of human brain homogenate cholinesterases inhibited by Tabun using newly developed oximes K117 and K127. Kuca K, Cabal J, Jung YS, Musilek K, Soukup O, Jun D, Pohanka M, Musilova L, Karasova J, Novotny L, Hrabinova M, Basic Clin Pharmacol Toxicol 2009 105 207 210 10.1111/j.1742-7843.2009.00421.x 19473310
156. Efficacy of HI-6 and HLo-7 in preventing incapacitation following nerve agent poisoning. Melchers BP, Philippens IH, Wolthuis OL, Pharmacol Biochem Behav 1994 49 781 788 10.1016/0091-3057(94)90223-2 7886087
157. Pharmacokinetics and effects of HI 6 in blood and brain of soman-intoxicated rats: a microdialysis study. Cassel G, Karlsson L, Waara L, Ang KW, Goransson-Nyberg A, Eur J Pharmacol 1997 332 43 52 10.1016/S0014- 2999(97)01058-3 9298924 (Pubitemid 27346602)
158. Efficacy of HLo-7 and pyrimidoxime as antidotes of nerve agent poisoning in mice. Clement JG, Hansen AS, Boulet CA, Arch Toxicol 1992 66 216 219 10.1007/BF01974018 1497487
159. The oxime pro-2-PAM provides minimal protection against the CNS effects of the nerve agents sarin, cyclosarin, and VX in guinea pigs. Shih TM, Guarisco JA, Myers TM, Kan RK, McDonough JH, Toxicol Mech Methods 2011 21 53 62 10.3109/15376516.2010.529190 21117832
160. Pyridoxine. Howland MA, Goldfrank's toxicologic emergencies New York: McGroHill, Nelson L, Lewin N, Howland MA, Hoffman R, Goldfrank L, Flomenbaum NE, ninth 2011 23261312
161. Critical care toxicology. Holstege CP, Dobmeier SG, Bechtel LK, Emerg Medi Clini Nor Am 2008 26 715 739 10.1016/j.emc.2008.04.003 (Pubitemid 352004098)
162. Chapter 5: Chemical agents. Greaves I, Hunt P, Responding to terrorism Edinburgh: Churchill Livingstone, Imre R, Mooney TB, Clarke B, 2010 233 344
163. Nerve and chemical agents. Mongan PD, Winkley J, Joseph HMI, Hospital preparation for bioterror Burlington: Academic Press 2006 73 88
164. Acute renal failure enhances the antidotal activity of pralidoxime towards paraoxon-induced respiratory toxicity. Kayouka M, Houzé P, Debray M, Baud FJ, Toxicol Lett 2009 189 48 56 10.1016/j.toxlet.2009.04.020 19406220
165. Acute renal failure alters the kinetics of pralidoxime in rats. Kayouka M, Houzé P, Risède P, Debray M, Baud FJ, Toxicol Lett 2009 184 61 66 10.1016/j.toxlet.2008.10.022 19026730
166. Effect of diazepam on the effectiveness of antidote therapy in eliminating the acute lethal effects of soman in mice. Kassa J, Cas Lek Cesk 2001 140 497 499 11678028 (Pubitemid 32842991)
167. Anticonvulsants for poisoning by the organophosphorus compound soman: pharmacological mechanisms. Shih TM, Koviak TA, Capacio BR, Neurosci Biobehav Rev 1991 15 349 362 10.1016/S0149-7634(05)80028-4 1683477
168. Anticonvulsants for nerve agent-induced seizures: The influence of the therapeutic dose of atropine. Shih TM, Rowland TC, McDonough JH, J Pharmacol Exp Ther 2007 320 154 161 17015638 (Pubitemid 46025730)
169. Percutaneous exposure to the nerve agent VX: Efficacy of combined atropine, obidoxime and diazepam treatment. Joosen MJ, van der Schans MJ, van Helden HP, Chem Biol Interact 2010 188 255 263 10.1016/j.cbi.2010.06.010 20599844
170. McDonough JH, Midazolam: An Improved Anticonvulsant Treatment for Nerve Agent-Induced Seizures 2002
171. Comparative evaluation of benzodiazepines for control of soman-induced seizures. McDonough JH Jr, McMonagle J, Copeland T, Zoeffel D, Shih TM, Arch Toxicol 1999 73 473 478 10.1007/s002040050637 10650919 (Pubitemid 30010249)
172. Anticonvulsant efficacy of drugs with cholinergic and/or glutamatergic antagonism microinfused into area tempestas of rats exposed to soman. Myhrer T, Enger S, Aas P, Neurochem Res 2008 33 348 354 10.1007/s11064-007-9429-3 17710542
173. Review of the value of gacyclidine (GK-11) as adjuvant medication to conventional treatments of organophosphate poisoning: primate experiments mimicking various scenarios of military or terrorist attack by soman. Lallement G, Baubichon D, Clarencon D, Galonnier M, Peoc'h M, Carpentier P, Neurotoxicology 1999 20 675 684 10499365 (Pubitemid 29420367)
174. Effects of the novel NMDA receptor antagonist gacyclidine on recovery from medial frontal cortex contusion injury in rats. Smith JS, Fulop ZL, Levinsohn SA, Darrell RS, Stein DG, Neural Plast 2000 7 73 91 10.1155/NP.2000.73 10709216 (Pubitemid 30224056)
175. Gacyclidine: a new neuroprotective agent acting at the N-methyl-D-aspartate receptor. Hirbec H, Gaviria M, Vignon J, CNS Drug Rev 2001 7 172 198 11474423 (Pubitemid 32656300)
176. The GluK1 (GluR5) Kainate/{alpha}-amino-3-hydroxy-5-methyl-4- isoxazolepropionic acid receptor antagonist LY293558 reduces soman-induced seizures and neuropathology. Figueiredo TH, Qashu F, Apland JP, Aroniadou-Anderjaska V, Souza AP, Braga MF, J Pharmacol Exp Ther 2011 336 303 312 10.1124/jpet.110.171835 20962029
177. Efficacy of the ketamine-atropine combination in the delayed treatment of soman-induced status epilepticus. Dorandeu F, Carpentier P, Baubichon D, Four E, Bernabe D, Burckhart MF, Lallement G, Brain Res 2005 1051 164 175 10.1016/j.brainres.2005.06.013 16005443 (Pubitemid 40982638)
178. Combinations of ketamine and atropine are neuroprotective and reduce neuroinflammation after a toxic status epilepticus in mice. Dhote F, Carpentier P, Barbier L, Peinnequin A, Baille V, Pernot F, Testylier G, Beaup C, Foquin A, Dorandeu F, Toxicol Appl Pharmacol 2012 259 195 209 10.1016/j.taap.2011.12.024 22245128
179. Huperzine A ameliorates the spatial working memory impairments induced by AF64A. Zhi QX, Yi FH, Xi CT, Neurorep 1995 6 2221 2224 10.1097/00001756- 199511000-00029
180. Huperzine A, a nootropic alkaloid, inhibits N-methyl-D-aspartate-induced current in rat dissociated hippocampal neurons. Zhang JM, Hu GY, Neurosci 2001 105 663 669 10.1016/S0306-4522(01)00206-8 (Pubitemid 32769830)
181. The psychopharmacology of huperzine A: an alkaloid with cognitive enhancing and neuroprotective properties of interest in the treatment of Alzheimer's disease. Zangara A, Pharmacol Biochem Behav 2003 75 675 686 10.1016/S0091-3057(03)00111-4 12895686 (Pubitemid 36939173)
182. [+]-Huperzine A treatment protects against N-methyl-D-aspartate-induced seizure/status epilepticus in rats. Coleman BR, Ratcliffe RH, Oguntayo SA, Shi X, Doctor BP, Gordon RK, Nambiar MP, Chem Biol Interact 2008 175 387 395 10.1016/j.cbi.2008.05.023 18588864
183. Huperzine A as a pretreatment candidate drug against nerve agent toxicity. Grunwald J, Raveh L, Doctor BP, Ashani Y, Life Sci 1994 54 991 997 10.1016/0024-3205(94)00501-X 8139389 (Pubitemid 24110164)
184. (-)Huperzine A, replacement for pyridostigmine bromide as nerve agent pretreatment, measured in Guinea Pig plasma by a new ultrahigh-pressure liquid chromatography (UHPLC)-MS method. Garcia GE, Vernon A, Moorad-Doctor D, Ratcliffe RH, FASEBJ 2009 23 Suppl
185. Different approaches to acute organophosphorus poison treatment. Nurulain SN, J Pak Med Assoc 2012 62 712 717
186. Standard antidotes along with sodium bicarbonate in organophosphate poisoning. Antonijvic B, Stefanovic D, Milovanovic ZA, Stojiljkovic MP, Bokonjic D, Dukic M, Proceedings of chemical and biological medical treatment symposium (CBMTS); Spiez, Switzerland 2002 April 28-May 3
187. GC-MS and LC-MS analysis of nerve agents in body fluids: intra-laboratory verification test using spiked plasma and urine samples. Koller M, Becker C, Thiermann H, Worek F, J Chromatogr B Analyt Technol Biomed Life Sci 2010 878 1226 1233 10.1016/j.jchromb.2009.12.023 20061191
188. Wide complex tachycardia in a pediatric diphenhydramine overdose treated with sodium bicarbonate. Cole JB, Stellpflug SJ, Gross EA, Smith SW, Pediatr Emerg Care 2011 27 1175 1177 10.1097/PEC.0b013e31823b0e47 22158278
189. Accidental organic phosphorus poisoning: the use of propranolol to counteract vagolytic cardiac effects of atropine. Valero A, Golan D, Isr J Med Sci 1967 3 582 584 6060576
190. Use of hemoperfusion in experimental intoxication with nerve agents. Monhart V, Fusek J, Brndiar M, Tlustakova M, Artif Organs 1994 18 770 772 10.1111/j.1525-1594.1994.tb03317.x 7832660 (Pubitemid 24336774)
191. Blood purification for severe sarin poisoning after the Tokyo subway attack. Yokoyama K, Ogura Y, Kishimoto M, Hinoshita F, Hara S, Yamada A, Mimura N, Seki A, Sakai O, JAMA 1995 274 379 7616626
192. Intravenous lipid emulsion in clinical toxicology. Rothschild L, Bern S, Oswald S, Weinberg G, Scand J Trauma Resusc Emerg Med 2010 18 51 10.1186/1757-7241-18-51 20923546
193. Intravenous lipid emulsions combine extracorporeal blood purification: a novel therapeutic strategy for severe organophosphate poisoning. Zhou Y, Zhan C, Li Y, Zhong Q, Pan H, Yang G, Med Hypotheses 2010 74 309 311 10.1016/j.mehy.2009.09.001 19786326
194. The Effect of Intralipid on organophosphate toxicity in mice. Bania TC, Chu J, Stolbach A, Acad Emerg Med 2005 12 Suppl. 1 7 12 15884181
195. Benefits of magnesium sulfate in the management of acute human poisoning by organophosphorus insecticides. Pajoumand A, Shadnia S, Rezaie A, Abdi M, Abdollahi M, Hum Exp Toxicol 2004 23 565 569 10.1191/0960327104ht489oa 15688984 (Pubitemid 40096859)
196. Magnesium sulphate enhances residual neuromuscular block induced by vecuronium. Fuchs-Buder T, Tassonyi E, Br J Anaesth 1996 76 565 566 10.1093/bja/76.4.565 8652332
197. Management of acute organophosphorus pesticide poisoning. Eddleston M, Buckley NA, Eyer P, Dawson AH, Lancet 2008 371 597 607 10.1016/S0140-6736(07) 61202-1 17706760 (Pubitemid 351232010)
198. Bronchodilating effect of intravenous magnesium sulfate in bronchial asthma. Okayama H, Aikawa T, Okayama M, Sasaki H, Mue S, Takishima T, JAMA 1987 257 1076 1078 10.1001/jama.1987.03390080066032 3806898 (Pubitemid 17031498)
199. Chapter 7: Nerve agent bioscavenger: Development of a new approach to protect against organophosphorus exposure. Ross MC, Broomfield CA, Cerasoli DM, Doctor BP, Lenz DE, Maxwell DM, Saxena A, Textbooks of military medicine,medical aspects of chemical warfare Washington, DC: The Office of the Surgeon General at TMM Publications, Lenhart MK, Tuorinsky SD, 2008 243 259
200. Effectiveness of fresh frozen plasma as supplementary treatment in organophosphate poisoning. Pazooki S, Solhi H, Vishteh HR, Shadnia S, Beigi MJ, Med J Malaysia 2011 66 342 345 22299554
201. Bioscavenger therapy for organophosphate poisoning-an open-labeled pilot randomized trial comparing fresh frozen plasma or albumin with saline in acute organophosphate poisoning in humans. Pichamuthu K, Jerobin J, Nair A, John G, Kamalesh J, Thomas K, Jose A, Fleming JJ, Zachariah A, David SS, et al. Clin Toxicol (Phila) 2010 48 813 819 10.3109/15563650.2010.518970
202. Interaction of soman with beta-cyclodextrin. Desire B, Saint-Andre S, Fundam Appl Toxicol 1986 7 646 657 3803759
203. Inactivation of sarin and soman by cyclodextrins in vitro. Desire B, Saint-Andre S, Experientia 1987 43 395 397 10.1007/BF01940424 3569488 (Pubitemid 17060935)
204. Detoxification of nerve agents by a substituted beta-cyclodextrin: application of a modified biological assay. Wille T, Tenberken O, Reiter G, Muller S, Le Provost R, Lafont O, Estour F, Thiermann H, Worek F, Toxicology 2009 265 96 100 10.1016/j.tox.2009.09.018 19800384
205. Effect of cytokine treatment on the neurogenesis process in the brain of soman-poisoned mice. Collombet JM, Four E, Burckhart MF, Masqueliez C, Bernabe D, Baubichon D, Herodin F, Lallement G, Toxicology 2005 210 9 23 10.1016/j.tox.2005.01.013 15804454 (Pubitemid 40459638)
206. Long-term effects of cytokine treatment on cognitive behavioral recovery and neuronal regeneration in soman-poisoned mice. Collombet JM, Beracochea D, Liscia P, Pierard C, Lallement G, Filliat P, Behav Brain Res 2011 221 261 270 10.1016/j.bbr.2011.03.006 21396966
207. Visualization of exogenous delivery of nanoformulated butyrylcholinesterase to the central nervous system. Gaydess A, Duysen E, Li Y, Gilman V, Kabanov A, Lockridge O, Bronich T, Chem Biol Interact 2010 187 295 298 10.1016/j.cbi.2010.01.005 20060815
208. Effectiveness of donepezil, rivastigmine, and (+/-)huperzine A in counteracting the acute toxicity of organophosphorus nerve agents: comparison with galantamine. Aracava Y, Pereira EF, Akkerman M, Adler M, Albuquerque EX, J Pharmacol Exp Ther 2009 331 1014 1024 10.1124/jpet.109.160028 19741148
209. Implication of chemical biological terrorist event for children and pregnant women. Teran-MacIver M, Larson K, MCN 2008 33 224 232 10.1097/RLU.0b013e31815976ca (Pubitemid 351301565)
210. Atropine use in children after nerve gas exposure. Pediatric Expert Advisory Panel Participants, Pediatric Expert Advisory Panel(PEAP) Addressing terrorism, Disaiter and public health emergency New York: Columbia University Maliman School of Public Health, National Center for Disaster Preparedness 2004 1 8
211. Chemical aspects of pharmacological prophylaxis against nerve agent poisoning. Bajgar J, Fusek J, Kassa J, Kuca K, Jun D, Curr Med Chem 2009 16 2977 2986 10.2174/092986709788803088 19689278
212. Anaesthesia and critical care considerations in nerve agent warfare trauma casualties. Weinbroum AA, Rudick V, Paret G, Kluger Y, Ben Abraham R, Resuscitation 2000 47 113 123 10.1016/S0300-9572(00)00216-1 11008149
213. Future applications of phosphotriesterases in the prophylaxis and treatment of organophosporus insecticide and nerve agent poisonings. Sogorb MA, Vilanova E, Carrera V, Toxicol Lett 2004 151 219 233 10.1016/j.toxlet.2004.01. 022 15177657 (Pubitemid 38739044)
214. Acetylcholinesterase prophylaxis against organophosphate toxicity. Wolfe AD, Rush RS, Doctor BP, Koplovitz I, Jones D, Fundam Appl Toxicol 1987 9 266 270 3653568 (Pubitemid 18043755)
215. Protein engineering of a human enzyme that hydrolyzes V and G nerve agents: design, construction and characterization. Broomfield CA, Lockridge O, Millard CB, Chem Biol Interact 1999 119-120 413 418 23131608 (Pubitemid 29278578)
216. Cholinesterase reactivators as prophylactics against nerve agents. Bajgar J, Kuca K, Fusek J, Jun D, Bartosova L, Curr Bioact Compd 2010 6 2 8 10.2174/157340710790711773
217. Original transdermal prophylactic antidote against nerve agents-TRANSANT. Bajgar J, Fusek J, Sevelova L, Kassa J, Chemical and biological medical treatment symposium; Spiez, Switzerland 2004 14 25-30 April 22628426